Correlation Between Scpharmaceuticals and Scopus Biopharma
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Scopus Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Scopus Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Scopus Biopharma, you can compare the effects of market volatilities on Scpharmaceuticals and Scopus Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Scopus Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Scopus Biopharma.
Diversification Opportunities for Scpharmaceuticals and Scopus Biopharma
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Scpharmaceuticals and Scopus is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Scopus Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scopus Biopharma and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Scopus Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scopus Biopharma has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Scopus Biopharma go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Scopus Biopharma
If you would invest 10.00 in Scopus Biopharma on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Scopus Biopharma or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 4.76% |
| Values | Daily Returns |
Scpharmaceuticals vs. Scopus Biopharma
Performance |
| Timeline |
| Scpharmaceuticals |
| Scopus Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Scpharmaceuticals and Scopus Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and Scopus Biopharma
The main advantage of trading using opposite Scpharmaceuticals and Scopus Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Scopus Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scopus Biopharma will offset losses from the drop in Scopus Biopharma's long position.| Scpharmaceuticals vs. Capricor Therapeutics | Scpharmaceuticals vs. Soleno Therapeutics | Scpharmaceuticals vs. Bio Path Holdings | Scpharmaceuticals vs. Moleculin Biotech |
| Scopus Biopharma vs. Scpharmaceuticals | Scopus Biopharma vs. DiaMedica Therapeutics | Scopus Biopharma vs. Monopar Therapeutics | Scopus Biopharma vs. Pasithea Therapeutics Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets |